Provided by Tiger Trade Technology Pte. Ltd.

Matinas BioPharma Holdings, Inc

0.1988
+0.01638.93%
Post-market: 0.1935-0.0053-2.67%19:53 EDT
Volume:832.85K
Turnover:160.57K
Market Cap:2.92M
PE:-0.17
High:0.2060
Open:0.1821
Low:0.1800
Close:0.1825
52wk High:2.24
52wk Low:0.1780
Shares:14.69M
Float Shares:11.60M
Volume Ratio:0.25
T/O Rate:7.18%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.1921
EPS(LYR):-2.0000
ROE:-141.23%
ROA:-56.17%
PB:1.62
PE(LYR):-0.10

Loading ...

Top Premarket Decliners

MT Newswires Live
·
Aug 20

Matinas BioPharma FY26 Q2 Net Loss Narrows to $3.25 Million

Reuters
·
Aug 14

Matinas BioPharma Agrees to Merge with GH Power in NYSE American Listing Deal

Reuters
·
Jul 30

GH Power and Tkms Continue to Explore Clean Energy Collaboration in Support of Canada’s Future Patrol Submarine Project

THOMSON REUTERS
·
Jul 30

Matinas Biopharma - Btig Terminates Sales Agreement with Matinas Biopharma Holdings, Effective Immediately on July 23, 2026 - SEC Filing

THOMSON REUTERS
·
Jul 25

Matinas Biopharma - Incurs no Termination Penalties or Expenses from Sales Agreement Termination - SEC Filing

THOMSON REUTERS
·
Jul 25

Top Premarket Decliners

MT Newswires Live
·
Jul 14

Matinas Biopharma to Combine with GH Power, Forming New Public Parent GH Power International

Reuters
·
Jul 14

GH Power - GH Power Pursuing Pipe Financing of at Least $15 Mln as Condition to Closing

THOMSON REUTERS
·
Jul 14

GH Power, the Pioneering Clean Energy and Critical Materials Company, to Go Public Through Business Combination with Matinas Biopharma

THOMSON REUTERS
·
Jul 14

GH Power - GH Power International to Become Public Parent Company of GH Power and Matinas

THOMSON REUTERS
·
Jul 14

Matinas Biopharma Agrees to Sell Nanotechnologies Unit to Azurity for USD 4 Million Upfront

Reuters
·
Jul 13

Matinas Biopharma Says Warrant Exercise Brings in About $2.6 Million Cash Proceeds

Reuters
·
Jul 13

Matinas Biopharma Announces Strategic Business Combination with GH Power to Create Publicly Traded, Advanced Clean Energy and Green Hydrogen Company; Signs Definitive Agreement to Sell Lnc Platform Technology and Lead Product Candidate Mat2203 to Azurity Pharmaceuticals

THOMSON REUTERS
·
Jul 13

Matinas Biopharma Holdings - GH Power Equityholders to Own 91% and Matinas Equityholders 9% of Ghp International Post-closing

THOMSON REUTERS
·
Jul 13

Matinas Biopharma Holdings - Each Matinas Common Share to be Converted into 0.1 Ghp International Common Share

THOMSON REUTERS
·
Jul 13

Matinas Biopharma- Proposed Deal for $4.0 Mln Upfront, up to an Additional $17.5 Mln in Potential Milestones and Future Mid-single-digit Royalties

THOMSON REUTERS
·
Jul 13

Matinas BioPharma receives noncompliance notification from NYSE

TIPRANKS
·
Jun 27

Matinas Biopharma Gets NYSE American Notice for Failing Stockholders’ Equity Listing Standard

Reuters
·
Jun 27

Matinas Biopharma Receives Notice of Non-compliance with NYSE American Continued Listing Standards and Acceptance of Plan to Regain Compliance

THOMSON REUTERS
·
Jun 27